Cite
Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.
MLA
Ferre-Aracil, Carlos, et al. “Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.” Digestive Diseases and Sciences, vol. 66, no. 8, Aug. 2021, pp. 2826–32. EBSCOhost, https://doi.org/10.1007/s10620-020-06569-9.
APA
Ferre-Aracil, C., Riveiro-Barciela, M., Trapero-Marugán, M., Rodríguez-Perálvarez, M., Llovet, L.-P., Téllez, L., Sánchez-Torrijos, Y., Díaz-Fontenla, F., Salcedo-Plaza, M., Álvarez-López, P., de la Mata, M., Londoño, M.-C., Bañares-Cañizares, R., & Calleja, J. L. (2021). Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study. Digestive Diseases and Sciences, 66(8), 2826–2832. https://doi.org/10.1007/s10620-020-06569-9
Chicago
Ferre-Aracil, Carlos, Mar Riveiro-Barciela, María Trapero-Marugán, Manuel Rodríguez-Perálvarez, Laura-Patricia Llovet, Luis Téllez, Yolanda Sánchez-Torrijos, et al. 2021. “Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.” Digestive Diseases and Sciences 66 (8): 2826–32. doi:10.1007/s10620-020-06569-9.